BlackRock Institutional Trust’s Anika Therapeutics ANIK Stock Holding History

BlackRock Institutional Trust’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$18.7M	Buy	382,051 +15,772	+4%	+$729K	﹤0.01%	2014
2016 Q3	$17.5M	Buy	366,279 +3,718	+1%	+$184K	﹤0.01%	1974
2016 Q2	$19.5M	Sell	362,561 -18,492	-5%	-$871K	﹤0.01%	1864
2016 Q1	$17M	Buy	381,053 +302	+0.1%	+$12.3K	﹤0.01%	1923
2015 Q4	$14.5M	Sell	380,751 -14,652	-4%	-$560K	﹤0.01%	2082
2015 Q3	$12.6M	Sell	395,403 -102,454	-21%	-$3.57M	﹤0.01%	2132
2015 Q2	$16.4M	Sell	497,857 -33,243	-6%	-$1.19M	﹤0.01%	2062
2015 Q1	$21.9M	Sell	531,100 -12,799	-2%	-$517K	﹤0.01%	1871
2014 Q4	$22.2M	Buy	543,899 +12,420	+2%	+$485K	﹤0.01%	1835
2014 Q3	$19.5M	Buy	531,479 +56,615	+12%	+$2.45M	﹤0.01%	1886
2014 Q2	$22M	Sell	474,864 -32,900	-6%	-$1.46M	﹤0.01%	1892
2014 Q1	$20.9M	Buy	507,764 +118,231	+30%	+$4.39M	﹤0.01%	1925
2013 Q4	$14.9M	Buy	389,533 +3,465	+0.9%	+$107K	﹤0.01%	2147
2013 Q3	$9.22M	Buy	386,068 +7,743	+2%	+$174K	﹤0.01%	2410
2013 Q2	$6.43M	Buy	+378,325	New	+$5.46M	﹤0.01%	2574

Other funds holding ANIK

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

AAM

AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BlackRock Institutional Trust's ANIK Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Anika Therapeutics (ANIK) stake by 4.3% in Q4 2016, buying an estimated $729K and bringing the position to 382,051 shares worth $18.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2014.

BlackRock Institutional Trust first reported a position in ANIK in Q2 2013 and has held it in 15 quarters since. The position peaked at $22.2M in Q4 2014. 158 funds tracked by Wall St. Rank hold ANIK as of Q4 2016.

BlackRock Institutional Trust held 382,051 shares of Anika Therapeutics worth $18.7M as of Q4 2016.
BlackRock Institutional Trust bought 15,772 Anika Therapeutics shares in Q4 2016, an estimated $729K.
Anika Therapeutics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2014 holding.
BlackRock Institutional Trust first reported a position in Anika Therapeutics in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's Anika Therapeutics position peaked at $22.2M in Q4 2014.
158 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.